(1R,5S)-N-(2-imidazo[1,2-a]pyridin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-6-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-7-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-indolizin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-5-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(7-methyl-1,2-benzoxazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(1-methylisoquinolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(8-methylquinazolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide

C137H168N28O9 — CID 161271827

IUPAC(1R,5S)-N-(2-imidazo[1,2-a]pyridin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-6-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-7-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-indolizin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-5-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(7-methyl-1,2-benzoxazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(1-methylisoquinolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(8-methylquinazolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide
SMILESCC(C)(NC(=O)C1[C@H]2CNC[C@@H]12)c1cc2ccccn2c1.CC(C)(NC(=O)C1[C@H]2CNC[C@@H]12)c1ccc2nccn2c1.CC(C)(NC(=O)C1[C@H]2CNC[C@@H]12)c1cccc2cnccc12.CC(C)(NC(=O)C1[C@H]2CNC[C@@H]12)c1ccn2ccnc2c1.CC(C)(NC(=O)C1[C@H]2CNC[C@@H]12)c1cn2ccccc2n1.Cc1cccc2c(C(C)(C)NC(=O)C3[C@H]4CNC[C@@H]34)ncnc12.Cc1cccc2c(C(C)(C)NC(=O)C3[C@H]4CNC[C@@H]34)noc12.Cc1ncc(C(C)(C)NC(=O)C2[C@H]3CNC[C@@H]23)c2ccccc12
InChIInChI=1S/C19H23N3O.C18H22N4O.C18H21N3O.C17H21N3O2.C17H21N3O.3C16H20N4O/c1-11-12-6-4-5-7-13(12)16(10-21-11)19(2,3)22-18(23)17-14-8-20-9-15(14)17;1-10-5-4-6-11-15(10)20-9-21-16(11)18(2,3)22-17(23)14-12-7-19-8-13(12)14;1-18(2,21-17(22)16-13-9-20-10-14(13)16)15-5-3-4-11-8-19-7-6-12(11)15;1-9-5-4-6-10-14(9)22-20-15(10)17(2,3)19-16(21)13-11-7-18-8-12(11)13;1-17(2,11-7-12-5-3-4-6-20(12)10-11)19-16(21)15-13-8-18-9-14(13)15;1-16(2,10-3-5-20-6-4-18-13(20)7-10)19-15(21)14-11-8-17-9-12(11)14;1-16(2,10-3-4-13-18-5-6-20(13)9-10)19-15(21)14-11-7-17-8-12(11)14;1-16(2,12-9-20-6-4-3-5-13(20)18-12)19-15(21)14-10-7-17-8-11(10)14/h4-7,10,14-15,17,20H,8-9H2,1-3H3,(H,22,23);4-6,9,12-14,19H,7-8H2,1-3H3,(H,22,23);3-8,13-14,16,20H,9-10H2,1-2H3,(H,21,22);4-6,11-13,18H,7-8H2,1-3H3,(H,19,21);3-7,10,13-15,18H,8-9H2,1-2H3,(H,19,21);3-7,11-12,14,17H,8-9H2,1-2H3,(H,19,21);3-6,9,11-12,14,17H,7-8H2,1-2H3,(H,19,21);3-6,9-11,14,17H,7-8H2,1-2H3,(H,19,21)/t14-,15+,17?;12-,13+,14?;13-,14+,16?;11-,12+,13?;13-,14+,15?;2*11-,12+,14?;10-,11+,14?
InChIKeyVDXPIQQHGXGDBT-RESHRQEGSA-N
MW2351.04 g/mol
LogP13.33
Rot. Bonds24

About (1R,5S)-N-(2-imidazo[1,2-a]pyridin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-6-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-7-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-indolizin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-5-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(7-methyl-1,2-benzoxazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(1-methylisoquinolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(8-methylquinazolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide

(1R,5S)-N-(2-imidazo[1,2-a]pyridin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-6-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-7-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-indolizin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-5-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(7-methyl-1,2-benzoxazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(1-methylisoquinolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(8-methylquinazolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide (PubChem CID 161271827) has the molecular formula C137H168N28O9 and a molecular weight of 2351.04 g/mol. Its IUPAC name is (1R,5S)-N-(2-imidazo[1,2-a]pyridin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-6-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-7-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-indolizin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-5-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(7-methyl-1,2-benzoxazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(1-methylisoquinolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(8-methylquinazolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide.

Molecular Properties

Compound Name(1R,5S)-N-(2-imidazo[1,2-a]pyridin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-6-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-7-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-indolizin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-5-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(7-methyl-1,2-benzoxazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(1-methylisoquinolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(8-methylquinazolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide
PubChem CID161271827
Molecular FormulaC137H168N28O9
Molecular Weight2351.04 g/mol
Exact Mass2349.35
IUPAC Name(1R,5S)-N-(2-imidazo[1,2-a]pyridin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-6-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-7-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-indolizin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-5-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(7-methyl-1,2-benzoxazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(1-methylisoquinolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(8-methylquinazolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide
SMILESCC(C)(NC(=O)C1[C@H]2CNC[C@@H]12)c1cc2ccccn2c1.CC(C)(NC(=O)C1[C@H]2CNC[C@@H]12)c1ccc2nccn2c1.CC(C)(NC(=O)C1[C@H]2CNC[C@@H]12)c1cccc2cnccc12.CC(C)(NC(=O)C1[C@H]2CNC[C@@H]12)c1ccn2ccnc2c1.CC(C)(NC(=O)C1[C@H]2CNC[C@@H]12)c1cn2ccccc2n1.Cc1cccc2c(C(C)(C)NC(=O)C3[C@H]4CNC[C@@H]34)ncnc12.Cc1cccc2c(C(C)(C)NC(=O)C3[C@H]4CNC[C@@H]34)noc12.Cc1ncc(C(C)(C)NC(=O)C2[C@H]3CNC[C@@H]23)c2ccccc12
InChIInChI=1S/C19H23N3O.C18H22N4O.C18H21N3O.C17H21N3O2.C17H21N3O.3C16H20N4O/c1-11-12-6-4-5-7-13(12)16(10-21-11)19(2,3)22-18(23)17-14-8-20-9-15(14)17;1-10-5-4-6-11-15(10)20-9-21-16(11)18(2,3)22-17(23)14-12-7-19-8-13(12)14;1-18(2,21-17(22)16-13-9-20-10-14(13)16)15-5-3-4-11-8-19-7-6-12(11)15;1-9-5-4-6-10-14(9)22-20-15(10)17(2,3)19-16(21)13-11-7-18-8-12(11)13;1-17(2,11-7-12-5-3-4-6-20(12)10-11)19-16(21)15-13-8-18-9-14(13)15;1-16(2,10-3-5-20-6-4-18-13(20)7-10)19-15(21)14-11-8-17-9-12(11)14;1-16(2,10-3-4-13-18-5-6-20(13)9-10)19-15(21)14-11-7-17-8-12(11)14;1-16(2,12-9-20-6-4-3-5-13(20)18-12)19-15(21)14-10-7-17-8-11(10)14/h4-7,10,14-15,17,20H,8-9H2,1-3H3,(H,22,23);4-6,9,12-14,19H,7-8H2,1-3H3,(H,22,23);3-8,13-14,16,20H,9-10H2,1-2H3,(H,21,22);4-6,11-13,18H,7-8H2,1-3H3,(H,19,21);3-7,10,13-15,18H,8-9H2,1-2H3,(H,19,21);3-7,11-12,14,17H,8-9H2,1-2H3,(H,19,21);3-6,9,11-12,14,17H,7-8H2,1-2H3,(H,19,21);3-6,9-11,14,17H,7-8H2,1-2H3,(H,19,21)/t14-,15+,17?;12-,13+,14?;13-,14+,16?;11-,12+,13?;13-,14+,15?;2*11-,12+,14?;10-,11+,14?
InChIKeyVDXPIQQHGXGDBT-RESHRQEGSA-N
XLogP13.33
TPSA462.94 Ų
H-Bond Donors16
H-Bond Acceptors29
Rotatable Bonds24
Heavy Atoms174
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002351.04
LogP ≤ 513.33
H-Bond Donors ≤ 516
H-Bond Acceptors ≤ 1029

Analyze (1R,5S)-N-(2-imidazo[1,2-a]pyridin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-6-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-7-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-indolizin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-5-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(7-methyl-1,2-benzoxazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(1-methylisoquinolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(8-methylquinazolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1R,5S)-N-(2-imidazo[1,2-a]pyridin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-6-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-7-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-indolizin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-5-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(7-methyl-1,2-benzoxazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(1-methylisoquinolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(8-methylquinazolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide?
The IUPAC name of (1R,5S)-N-(2-imidazo[1,2-a]pyridin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-6-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-7-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-indolizin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-5-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(7-methyl-1,2-benzoxazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(1-methylisoquinolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(8-methylquinazolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide (CID 161271827) is (1R,5S)-N-(2-imidazo[1,2-a]pyridin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-6-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-7-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-indolizin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-5-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(7-methyl-1,2-benzoxazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(1-methylisoquinolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(8-methylquinazolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide.
What is the SMILES notation for (1R,5S)-N-(2-imidazo[1,2-a]pyridin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-6-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-7-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-indolizin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-5-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(7-methyl-1,2-benzoxazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(1-methylisoquinolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(8-methylquinazolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide?
The canonical SMILES for (1R,5S)-N-(2-imidazo[1,2-a]pyridin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-6-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-7-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-indolizin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-5-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(7-methyl-1,2-benzoxazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(1-methylisoquinolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(8-methylquinazolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide is CC(C)(NC(=O)C1[C@H]2CNC[C@@H]12)c1cc2ccccn2c1.CC(C)(NC(=O)C1[C@H]2CNC[C@@H]12)c1ccc2nccn2c1.CC(C)(NC(=O)C1[C@H]2CNC[C@@H]12)c1cccc2cnccc12.CC(C)(NC(=O)C1[C@H]2CNC[C@@H]12)c1ccn2ccnc2c1.CC(C)(NC(=O)C1[C@H]2CNC[C@@H]12)c1cn2ccccc2n1.Cc1cccc2c(C(C)(C)NC(=O)C3[C@H]4CNC[C@@H]34)ncnc12.Cc1cccc2c(C(C)(C)NC(=O)C3[C@H]4CNC[C@@H]34)noc12.Cc1ncc(C(C)(C)NC(=O)C2[C@H]3CNC[C@@H]23)c2ccccc12.
What is the InChIKey of (1R,5S)-N-(2-imidazo[1,2-a]pyridin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-6-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-7-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-indolizin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-5-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(7-methyl-1,2-benzoxazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(1-methylisoquinolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(8-methylquinazolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide?
The InChIKey is VDXPIQQHGXGDBT-RESHRQEGSA-N. The full InChI is InChI=1S/C19H23N3O.C18H22N4O.C18H21N3O.C17H21N3O2.C17H21N3O.3C16H20N4O/c1-11-12-6-4-5-7-13(12)16(10-21-11)19(2,3)22-18(23)17-14-8-20-9-15(14)17;1-10-5-4-6-11-15(10)20-9-21-16(11)18(2,3)22-17(23)14-12-7-19-8-13(12)14;1-18(2,21-17(22)16-13-9-20-10-14(13)16)15-5-3-4-11-8-19-7-6-12(11)15;1-9-5-4-6-10-14(9)22-20-15(10)17(2,3)19-16(21)13-11-7-18-8-12(11)13;1-17(2,11-7-12-5-3-4-6-20(12)10-11)19-16(21)15-13-8-18-9-14(13)15;1-16(2,10-3-5-20-6-4-18-13(20)7-10)19-15(21)14-11-8-17-9-12(11)14;1-16(2,10-3-4-13-18-5-6-20(13)9-10)19-15(21)14-11-7-17-8-12(11)14;1-16(2,12-9-20-6-4-3-5-13(20)18-12)19-15(21)14-10-7-17-8-11(10)14/h4-7,10,14-15,17,20H,8-9H2,1-3H3,(H,22,23);4-6,9,12-14,19H,7-8H2,1-3H3,(H,22,23);3-8,13-14,16,20H,9-10H2,1-2H3,(H,21,22);4-6,11-13,18H,7-8H2,1-3H3,(H,19,21);3-7,10,13-15,18H,8-9H2,1-2H3,(H,19,21);3-7,11-12,14,17H,8-9H2,1-2H3,(H,19,21);3-6,9,11-12,14,17H,7-8H2,1-2H3,(H,19,21);3-6,9-11,14,17H,7-8H2,1-2H3,(H,19,21)/t14-,15+,17?;12-,13+,14?;13-,14+,16?;11-,12+,13?;13-,14+,15?;2*11-,12+,14?;10-,11+,14?.
What are the key properties of (1R,5S)-N-(2-imidazo[1,2-a]pyridin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-6-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-7-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-indolizin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-5-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(7-methyl-1,2-benzoxazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(1-methylisoquinolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(8-methylquinazolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide?
(1R,5S)-N-(2-imidazo[1,2-a]pyridin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-6-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-7-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-indolizin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-5-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(7-methyl-1,2-benzoxazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(1-methylisoquinolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(8-methylquinazolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide has a molecular weight of 2351.04 g/mol, XLogP of 13.33, 24 rotatable bonds, 16 hydrogen bond donors, and 29 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,5S)-N-(2-imidazo[1,2-a]pyridin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-6-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-imidazo[1,2-a]pyridin-7-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-indolizin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-isoquinolin-5-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(7-methyl-1,2-benzoxazol-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(1-methylisoquinolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-(8-methylquinazolin-4-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide is sourced from PubChem (CID 161271827), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).